Redeye: BONESUPPORT Q1 - Short-sighted reaction on solid report
Redeye is encouraged to see a slightly higher-than-expected sales development for US CERAMENT G and a strong EBIT margin, cementing the thesis of a profitable high-sales growth journey ahead. We make no changes to our base case, which we expect to be reached in the coming 12 months.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/